Form 8-K Adaptimmune Therapeutics For: Nov 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Adaptimmune Therapeutics (ADAP) Tops Q3 EPS by 2c
November 10, 2016 6:33 AM ESTAdaptimmune Therapeutics (NASDAQ: ADAP) reported Q3 EPS of ($0.26), $0.02 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $5.32 million.
For earnings history and earnings-related data on Adaptimmune Therapeutics (ADAP) click here.
... More